Tyzeka FDA Approval History
FDA Approved: Yes (Discontinued) (First approved October 25, 2006)
Brand name: Tyzeka
Generic name: telbivudine
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: Hepatitis B
Marketing Status: Discontinued
Tyzeka (telbivudine) is a synthetic thymidine nucleoside analogue indicated for the treatment of chronic hepatitis B.
Development timeline for Tyzeka
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
